HEALTHSTORY 758· JULY 4, 2026

Protillion Biosciences Names Robert Hollingsworth Chief Scientific Officer

Protillion Biosciences has hired Robert Hollingsworth as its chief scientific officer, according to the STAT+ executive-tracking column "Up and Down the Ladder." Hollingsworth previously held the same title at Shoreline Therapeutics and…

NDNewsDialy Desk2 MIN READPFE

SOURCE

statnews.com

← PREVIOUS STORY 757Neugebauer Halts Fermi Proxy Campaign Despite 70% Shareholder Support After Judge's Last-Minute Recusal Derails Timeline NEXT STORY 759 →Elevance Health Sues U.S. Government for $115 Million Over Medicare Advantage Star Ratings

Keep reading

More from the desk.

04HEALTH

ADA internal review clears group of censorship after members ejected in New Orleans

An internal review, meaning an investigation the organization runs into its own conduct using a committee it appoints, has cleared the American Diabetes Association of censoring five members ejected from its scientific conference in New…

health2 MIN

29HEALTH

GLP-1 drugs are forcing employers to reconsider how they pay for workers' health care

A class of prescription medications known as GLP-1 drugs is upending how employers pay for their workers' health coverage. STAT's Health Care Inc. newsletter, written by reporter Bob Herman, describes

health1 MIN

33HEALTH

A federal court will test whether buying a drug patent application can extend a monopoly illegally

Buying a patent application, a government filing that claims rights to an invention before the patent is officially issued, may be enough to cross the line into anticompetitive behavior. That question sits at the center of a federal…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk